<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">225</article-id>
      <article-id pub-id-type="doi">10.31348/2021/37</article-id>
      <article-categories>
        <subj-group>
          <subject>Case report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Intraocular Lymphoma with Retrobulbar Infiltration. A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jurenová</surname>
            <given-names>Denisa</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Plesníková</surname>
            <given-names>Paulína</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-7399-8517</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lysková</surname>
            <given-names>Darina</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Babál</surname>
            <given-names>Pavel</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kobzová</surname>
            <given-names>Daniela</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Furdová</surname>
            <given-names>Alena</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>25</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <issue>6</issue>
      <elocation-id>6</elocation-id>
      <abstract>
        <p>Subjective and objective symptoms following intraocular lymphoma could lead to a misdiagnosing at the beginning of disease what is the cause for delay of an effective treatment. The most common manifestation of lymphoma is an inflammatory disease affecting uvea. A multidisciplinary approach to the diagnosis is required. Suspicion based on the ophthalmologic examinations has to be verified by histology. We present a case report of a 78-year-old patient examined at our clinic with progressive loss of vision on the left eye in 6 months, suspected of retinal detachment. Objectively the visual acuity was counting fingers in front of the left eye. Intraocular pressure changed from normotensive into hypertensive values during regular examinations. We realised imaging exams, ultrasonography and magnetic resonance, which proved intraocular tumour with retrobulbar infiltration and retinal detachment. The patient was indicated for enucleation which enabled assignment of a histologic type of intraocular lymphoma B-Non-Hodgkin lymphoma from marginal zone B-cells. We sent the patient to a haematologist-oncologist for managing of the following treatment and we prescribed individual prosthesis to the patient after the enucleation. The patient remains in observation, no surgical treatment, chemotherapy or radiotherapy have been used for 23 months after the enucleation. The enucleation was both a diagnostic and treatment modality.</p>
      </abstract>
      <kwd-group>
        <kwd>intraocular lymphoma</kwd>
        <kwd>B-Non-Hodgkin lymphoma</kwd>
        <kwd>enucleation</kwd>
        <kwd>intraocular tumours</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R5472">
        <mixed-citation>Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008 Aug;36(6):564-578. doi: 10.1111/j.1442- 9071.2008.01843.x<pub-id pub-id-type="doi">10.1111/j.1442-</pub-id></mixed-citation>
      </ref>
      <ref id="R5473">
        <mixed-citation>Tang L-J, Gu C-L, Zhang P. Incraocular lymphoma. Int J Ophthalmol. 2017;10(8):1301-1307. doi: 10.18240/ijo.2017.08.19<pub-id pub-id-type="doi">10.18240/ijo.2017.08.19</pub-id></mixed-citation>
      </ref>
      <ref id="R5474">
        <mixed-citation>Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014 Sep-Oct;59(5):503-516. doi: 10.1016/j.survophthal.2013.12.001<pub-id pub-id-type="doi">10.1016/j.survophthal.2013.12.001</pub-id></mixed-citation>
      </ref>
      <ref id="R5475">
        <mixed-citation>Reddy EK, Bhatia P, Evans RG. Primary orbital lymphomas. Int J Radiat Oncol Biol Phys. 1988 Nov;15(5):1239-1241. doi: 10.1016/0360- 3016(88)90210-6<pub-id pub-id-type="doi">10.1016/0360-</pub-id></mixed-citation>
      </ref>
      <ref id="R5476">
        <mixed-citation>Cho B-J, Yu HG. Risk factors for intraocular involvement in patients with primary central nervous system lymphoma. J Neurooncol. 2014 Dec;120(3):523-529. doi: 10.1007/s11060-014- 1581-4<pub-id pub-id-type="doi">10.1007/s11060-014-</pub-id></mixed-citation>
      </ref>
      <ref id="R5477">
        <mixed-citation>Sobrin L, Dubovy SR, Davis JL, Murray TG. Isolated, bilateral intraocular lymphoma in a 15-year-old girl. Retina. 2005 Apr- May;25(3):370-373. doi: 10.1097/00006982-200504000-00021<pub-id pub-id-type="doi">10.1097/00006982-200504000-00021</pub-id></mixed-citation>
      </ref>
      <ref id="R5478">
        <mixed-citation>Wender A. Primary B-Cell Lymphoma of the Eyes and Brain in a 3-Year-Old Boy. Arch Ophthalmol. 1994 Apr;112(4):450-451. doi: 10.1001/archopht.1994.01090160024009<pub-id pub-id-type="doi">10.1001/archopht.1994.01090160024009</pub-id></mixed-citation>
      </ref>
      <ref id="R5479">
        <mixed-citation>Chan S. Iris lymphoma in a pediatric cardiac transplant recipient Clinicopathologic findings. Ophthalmology. 2000 Aug;107(8):1479-1482. doi: 10.1016/s0161-6420(00)00172-x<pub-id pub-id-type="doi">10.1016/s0161-6420(00)00172-x</pub-id></mixed-citation>
      </ref>
      <ref id="R5480">
        <mixed-citation>Berenbom A, Davila RM, Lin H-S, Harbour JW. Treatment outcomes for primary intraocular lymphoma: implications for external logical or histological examination with immunohistochemical analysis. Samples can be taken by thin-needle aspiration biopsy of the vitreous cavity or by pars plana vitrectomy, although the result is often false-negative due to insufficient capture of malignant cells [2]. The vitreous cavity contains reactive T-lymphocytes, necrotic cells, debris, fibrin, which impedes the identification of malignant cells [28]. Pars plana vitrectomy usually improves visual acuity, after removal of the content of the vitreous cavity, but at the same time there may be an iatrogenic spread of malignant lymphoma cells into the epibulbar space [29]. Retinal and subretinal infiltrates require sampling by retinotomy via an intraocular or transscleral approach [22]. In cases where the affected eye does not fulfil its function, or where it is not possible to choose conservative treatment, <pub-id pub-id-type="doi">10.1038/sj</pub-id></mixed-citation>
      </ref>
      <ref id="R5481">
        <mixed-citation>Buettner H, Bolling JP. Intravitreal Large-Cell Lymphoma. Mayo Clin Proc. 1993 Oct;68(10):1011-1015. doi: 10.1016/s0025-6196(12)62276- 9<pub-id pub-id-type="doi">10.1016/s0025-6196(12)62276-</pub-id></mixed-citation>
      </ref>
      <ref id="R5482">
        <mixed-citation>Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer. 1993 Aug;72(3):843-849. doi: 10.1002/1097-0142(19930801)72:3&lt;843: aid-cncr2820720333&gt;3.0. co;2-#<pub-id pub-id-type="doi">10.1002/1097-0142(19930801)72:3</pub-id></mixed-citation>
      </ref>
      <ref id="R5483">
        <mixed-citation>Furdová A, Marková A, Kapitánová K, Zahorjanová P. Treatment results in patients with lymphoma disease in the orbital region. Cesk Slov Oftalmol. 2017;73(5-6):211-217. Available from: http://www. cs-ophthalmology.cz/en/journal/articles/32</mixed-citation>
      </ref>
      <ref id="R5484">
        <mixed-citation>Melson MR, Mukai S. Intraocular Lymphoma. Int Ophthalmol Clin. 2006;46(2):69-77. doi: 10.1097/00004397-200604620-00008<pub-id pub-id-type="doi">10.1097/00004397-200604620-00008</pub-id></mixed-citation>
      </ref>
      <ref id="R5485">
        <mixed-citation>Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993 Sep;100(9):1399-1406. doi: 10.1016/s0161-6420(93)31469-7<pub-id pub-id-type="doi">10.1016/s0161-6420(93)31469-7</pub-id></mixed-citation>
      </ref>
      <ref id="R5486">
        <mixed-citation>Chan C-C, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002 Dec;13(6):411-418. doi: 10.1097/00055735- 200212000-00012<pub-id pub-id-type="doi">10.1097/00055735-</pub-id></mixed-citation>
      </ref>
      <ref id="R5487">
        <mixed-citation>Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004 Nov;242(11):901-913. doi: 10.1007/s00417-004-0973-0<pub-id pub-id-type="doi">10.1007/s00417-004-0973-0</pub-id></mixed-citation>
      </ref>
      <ref id="R5488">
        <mixed-citation>Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000 Dec;8(4):243-250. doi: 10.1076/ocii.8.4.243.6463<pub-id pub-id-type="doi">10.1076/ocii.8.4.243.6463</pub-id></mixed-citation>
      </ref>
      <ref id="R5489">
        <mixed-citation>Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol. 2007 Nov;18(11):1851-1855. doi: 10.1093/annonc/mdm340<pub-id pub-id-type="doi">10.1093/annonc/mdm340</pub-id></mixed-citation>
      </ref>
      <ref id="R5490">
        <mixed-citation>Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye. 2003 May;17(4):513-521. doi: 10.1038/sj.eye.6700378<pub-id pub-id-type="doi">10.1038/sj.eye.6700378</pub-id></mixed-citation>
      </ref>
      <ref id="R5491">
        <mixed-citation>Batis V, Shuttleworth J, Shuttleworth G, Williams GS. Diagnostic dilemma of ocular lymphoma. BMJ Case Rep. 2019 Jun;12(6):e229513. doi: 10.1136/bcr-2019-229513<pub-id pub-id-type="doi">10.1136/bcr-2019-229513</pub-id></mixed-citation>
      </ref>
      <ref id="R5492">
        <mixed-citation>Vosganian GS, Boisot S, Hartmann KI, et al. Primary intraocular lymphoma: a review. J Neurooncol. 2011 Nov;105(2):127-134. doi: 10.1007/s11060-011-0618-1<pub-id pub-id-type="doi">10.1007/s11060-011-0618-1</pub-id></mixed-citation>
      </ref>
      <ref id="R5493">
        <mixed-citation>Bardenstein DS. Intraocular Lymphoma: Intraocular lymphoma is the most elusive intraocular tumor to diagnose. Cancer Control. 1998;5(4):317-325. doi: 10.1177/107327489800500403<pub-id pub-id-type="doi">10.1177/107327489800500403</pub-id></mixed-citation>
      </ref>
      <ref id="R5494">
        <mixed-citation>Choi JY, Kafkala C, Foster CS. Primary Intraocular Lymphoma: A Review. Semin Ophthalmol. 2006;21(3):125-133. doi: 10.1080/08820530500350498<pub-id pub-id-type="doi">10.1080/08820530500350498</pub-id></mixed-citation>
      </ref>
      <ref id="R5495">
        <mixed-citation>Dean JM, Novak MA, Chan CC, Green WR. Tumor detachments of the retinal pigment epithelium in ocular/ central nervous system lymphoma. Retina. 1996;16(1):47-56. doi: 10.1097/00006982- 199616010-00009<pub-id pub-id-type="doi">10.1097/00006982-</pub-id></mixed-citation>
      </ref>
      <ref id="R5496">
        <mixed-citation>Fardeau C, Lee CPL, Merle-Béral H, et al. Retinal Fluorescein, Indocyanine Green Angiography, and Optic Coherence Tomography in Non-Hodgkin Primary Intraocular Lymphoma. Am J Ophthalmol. 2009;147(5):886-894.e1. doi: 10.1016/j.ajo.2008.12.025<pub-id pub-id-type="doi">10.1016/j.ajo.2008.12.025</pub-id></mixed-citation>
      </ref>
      <ref id="R5497">
        <mixed-citation>Garweg JG, Wanner D, Sarra G-M, et al. The diagnostic yield of vitrectomy specimen analysis in chronic idiopathic endogenous uveitis. Eur J Ophthalmol. 2006;16(4):588-594. doi: 10.1177/112067210601600414<pub-id pub-id-type="doi">10.1177/112067210601600414</pub-id></mixed-citation>
      </ref>
      <ref id="R5498">
        <mixed-citation>Chan C-C, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11(5):285-295. doi: 10.1177/107327480401100502<pub-id pub-id-type="doi">10.1177/107327480401100502</pub-id></mixed-citation>
      </ref>
      <ref id="R5499">
        <mixed-citation>Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):860-870. doi: 10.1007/s00417-003-0749-y<pub-id pub-id-type="doi">10.1007/s00417-003-0749-y</pub-id></mixed-citation>
      </ref>
      <ref id="R5500">
        <mixed-citation>Cursiefen C. Holbach LM, Lafaut B, Heimann K, Kirchner T, Naumann GO. Oculocerebral Non-Hodgkin’s Lymphoma With Uveal Involvement Development of an Epibulbar Tumor After Vitrectomy. Arch Ophthalmol. 2000;118(10):1437-1440. doi:10.1001/archopht.118.10.1437<pub-id pub-id-type="doi">10.1001/archopht.118.10.1437</pub-id></mixed-citation>
      </ref>
      <ref id="R5501">
        <mixed-citation>Trudeau M, Shepherd FA, Blackstein ME, Gospodarowicz M, Fitzpatrick P, Moffatt KP. Intraocular lymphoma: report of three cases and review of the literature. Am J Clin Oncol. 1988;11(2):126-130.</mixed-citation>
      </ref>
      <ref id="R5502">
        <mixed-citation>Faia LJ, Chan C-C. Primary intraocular lymphoma. Arch Pathol Lab Med. 2009;133(8):1228-1232. doi: 10.1043/1543-2165-133.8.1228<pub-id pub-id-type="doi">10.1043/1543-2165-133.8.1228</pub-id></mixed-citation>
      </ref>
      <ref id="R5503">
        <mixed-citation>Mason JO, Fischer DH. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma. Ophthalmology. 2003;110(6):1241-1244. doi: 10.1016/S0161-6420(03)00268-9<pub-id pub-id-type="doi">10.1016/S0161-6420(03)00268-9</pub-id></mixed-citation>
      </ref>
      <ref id="R5504">
        <mixed-citation>Sandor V, Stark-Vancs V, Pearson D, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol. 1998 Sep;16(9):3000-3006. doi: 10.1200/JCO.1998.16.9.3000<pub-id pub-id-type="doi">10.1200/JCO.1998.16.9.3000</pub-id></mixed-citation>
      </ref>
      <ref id="R5505">
        <mixed-citation>de Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol. 1999 Apr;83(4):448-451. doi: 10.1136/bjo.83.4.448<pub-id pub-id-type="doi">10.1136/bjo.83.4.448</pub-id></mixed-citation>
      </ref>
      <ref id="R5506">
        <mixed-citation>Sou R, Ohguro N, Maeda T, Saishin Y, Tano Y. Treatment of primary intraocular lymphoma with intravitreal methotrexate. Jpn J Ophthalmol. 2008;52(3):167-174. doi: 10.1007/s10384-008-0519-9<pub-id pub-id-type="doi">10.1007/s10384-008-0519-9</pub-id></mixed-citation>
      </ref>
      <ref id="R5507">
        <mixed-citation>Itty S, Pulido JS. Rituximab for Intraocular Lymphoma: Retina. 2009 Feb;29(2):129-132. doi: 10.1097/IAE.0b013e318192f574<pub-id pub-id-type="doi">10.1097/IAE.0b013e318192f574</pub-id></mixed-citation>
      </ref>
      <ref id="R5508">
        <mixed-citation>Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of rituximab. Eye. 2007 Dec;21(12):1524-1527. doi: 10.1038/sj.eye.6702804<pub-id pub-id-type="doi">10.1038/sj.eye.6702804</pub-id></mixed-citation>
      </ref>
      <ref id="R5509">
        <mixed-citation>Ohguro N, Hashida N, Tano Y. Effect of Intravitreous Rituximab Injections in Patients With Recurrent Ocular Lesions Associated With Central Nervous System Lymphoma. Arch Ophthalmol. 2008;126(7):1002-1003. doi: 10.1001/archopht.126.7.1002<pub-id pub-id-type="doi">10.1001/archopht.126.7.1002</pub-id></mixed-citation>
      </ref>
      <ref id="R5510">
        <mixed-citation>Soussain C, Hoang-Xuan K, Levy V. Chimiothérapie intensive avec support hématopoïétique chez 22 patients ayant un lymphome primitif du système nerveux central ou un lymphome intraoculaire réfractaire ou en rechute : mise à jour des résultats [Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma]. Bull Cancer. 2004 Feb;91(2):189-192. French.</mixed-citation>
      </ref>
      <ref id="R5511">
        <mixed-citation>Abrey LE, Moskowitz CH, Mason WP, et al. Intensive Methotrexate and Cytarabine Followed by High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Newly Diagnosed Primary CNS Lymphoma: An Intent-to-Treat Analysis. J Clin Oncol. 2003 Nov;21(22):4151-4156. doi: 10.1200/JCO.2003.05.024<pub-id pub-id-type="doi">10.1200/JCO.2003.05.024</pub-id></mixed-citation>
      </ref>
      <ref id="R5512">
        <mixed-citation>Chow PP-C, Ho SL, Lai WW, Au WY. Enucleation of painful blind eye for refractory intraocular lymphoma after dose-limiting chemotherapy and radiotherapy. Ann Hematol. 2012;91(10):1657-1658. doi: https://doi.org/10.1007/s00277-012-1452-z<pub-id pub-id-type="doi">10.1007/s00277-012-1452-z</pub-id></mixed-citation>
      </ref>
      <ref id="R5513">
        <mixed-citation>Albadri ST, Pulido JS, Macon WR, Garcia JJ, Salomao DR. Histologic findings in vitreoretinal lymphoma: learning from enucleation specimens. Retina. 2020 Feb;40(2):391-398. doi: 10.1097/ IAE.0000000000002676</mixed-citation>
      </ref>
      <ref id="R5514">
        <mixed-citation>Burnier SV, Burnier MN. Linfoma sistêmico de células B com manifestação ocular e extensão extraocular [Systemic B-cell lymphoma with ocular manifestation and extraocular extension]. Arq Bras Oftalmol. 1997;60(6). doi: 10.5935/0004-2749.19970015<pub-id pub-id-type="doi">10.5935/0004-2749.19970015</pub-id></mixed-citation>
      </ref>
      <ref id="R5515">
        <mixed-citation>Sood AB, Yeh S, Mendoza P, Grossniklaus HE. Histopathologic Diagnosis of Atypical Primary Vitreoretinal Lymphoma following Enucleation. Ocul Oncol Pathol. 2016;2(4):242-245. doi: 10.1159/000446605<pub-id pub-id-type="doi">10.1159/000446605</pub-id></mixed-citation>
      </ref>
      <ref id="R5516">
        <mixed-citation>Aronow ME, Portell CA, Sweetenham JW, Singh AD. Uveal Lymphoma: Clinical Features, Diagnostic Studies, Treatment Selection, and Outcomes. Ophthalmology. 2014;121(1):334-41. doi: https://doi. org/10.1016/j.ophtha.2013.09.004<pub-id pub-id-type="doi">10.1016/j.ophtha.2013.09.004</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
